Journal
SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41598-021-86200-7
Keywords
-
Categories
Funding
- Winn Feline Foundation [MT19-001]
Ask authors/readers for more resources
The study demonstrates the effectiveness of whole exome sequencing (WES) as a method to investigate genetic disease variants in domestic cats, enabling the identification of pathogenic gene variants for diseases and traits. Utilizing an exome capture design based on the annotated Felis_catus_9.0 genome assembly, WES was performed on 41 cats, revealing both known pathogenic variants and new gene candidate variants.
Over 94 million domestic cats are susceptible to cancers and other common and rare diseases. Whole exome sequencing (WES) is a proven strategy to study these disease-causing variants. Presented is a 35.7 Mb exome capture design based on the annotated Felis_catus_9.0 genome assembly, covering 201,683 regions of the cat genome. Whole exome sequencing was conducted on 41 cats with known and unknown genetic diseases and traits, of which ten cats had matching whole genome sequence (WGS) data available, used to validate WES performance. At 80xmean exome depth of coverage, 96.4% of on-target base coverage had a sequencing depth >20-fold, while over 98% of single nucleotide variants (SNVs) identified by WGS were also identified by WES. Platform-specific SNVs were restricted to sex chromosomes and a small number of olfactory receptor genes. Within the 41 cats, we identified 31 previously known causal variants and discovered new gene candidate variants, including novel missense variance for polycystic kidney disease and atrichia in the Peterbald cat. These results show the utility of WES to identify novel gene candidate alleles for diseases and traits for the first time in a feline model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available